CVC provides €500m financing with ESG-linked margin ratchet
![Pharmaceutical research, conceptual image.](https://assets.euromoneydigital.com/dims4/default/1d59553/2147483647/strip/true/crop/575x375+0+0/resize/840x548!/quality/90/?url=http%3A%2F%2Feuromoney-brightspot.s3.amazonaws.com%2F46%2Fce%2Fd9d070a44e51a0a4bdb6129f3fda%2Fpharmathen-alamy-575x375.jpg)
Deal finances Partners' acquisition of Greece's Pharmathen
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
The content you are trying to view is exclusive to our subscribers.
To unlock this article: